Long-term sequelae of severe acute respiratory coronavirus

Image

Institutional based cross-sectional study was conducted from among 403 undergraduate health sciences students at Bahir Dar Health Sciences Colleges. Simple random sampling technique was applied to select study subject and the data was collected by using a self-administered questionnaire. Data template format were prepared and entered into Epi Data and exported to SPSS version 25 for analysis. In binary logistic regression of dependent and independent variables with P-value, were included in multi-variable logistic regression and ≤ 0.05 were considered as significant in this study

About 147 of study participants were clinically competent which was higher than previous studies conducted in Ethiopia. providing logbooks, adequate clinical cases, preceptor show different procedures, student’s confidence and suitability of the way of teaching to the learning styles of students were significantly associated with clinical practice competence. Implementing logbooks, selection of clinical site, enhancing confidence of students, preferred teaching and learning styles and clinical preceptor support are important to improve the clinical competence of students.

Long-term sequelae of severe acute respiratory coronavirus-2 SARS-CoV-2 infection may include an increased incidence of diabetes. Our objective was to describe the temporal relationship between new diagnoses of diabetes mellitus and SARS-CoV-2 infection in a nationally representative database. There appears to be a sharp increase in diabetes diagnoses in the 30 days surrounding SARS-CoV-2 infection, followed by a decrease in new diagnoses in the post-acute period, up to 360 days after infection. These results underscore the need for further investigation, as understanding the timing of new diabetes onset after COVID-19 has implications regarding potential etiology and screening and treatment strategies

TS does not accept personal compensation of any kind from any pharmaceutical company and owns stock in Novartis Roche and Novo Nordis. JBB contracted consulting fees and travel support for contracted activities are paid to the University of North Carolina by Adocia AstraZeneca Eli Lilly Intarcia Therapeutics MannKind Novo Nordisk Sanofi Senseonics and vTv Therapeutics. JBB reports grant support from AstraZeneca Dexcom Eli Lilly Intarcia Therapeutics Johnson & Johnson Lexicon NovaTarg Novo Nordisk Sanofi Theracos Tolerion and vTv Therapeutics. JBB has received fees for consultation from Anji Pharmaceuticals AstraZeneca Boehringer Ingelheim Cirius Therapeutics Inc Eli Lilly Fortress Biotech Janssen Mellitus Health Moderna Pendulum Therapeutics Praetego Stability Health and Zealand Pharma. JBB holds stock/options in Mellitus Health Pendulum Therapeutics PhaseBio Praetego and Stability Health. JBB is supported by grants from the National Institutes of Health Patient Centered Outcomes Research Institute Juvenile Diabetes Research Foundation International and the American Diabetes Association.